C12R2001/89

Method of purification of recombinant osteopontin from micro algae

Provided herein are methods for obtaining purified recombinant osteopontin (rOPN) from cultures of transgenic microalgae, as well as nutritional supplements from such cultures.

Strain of bacteria producing DHA and EPA, six gene fragments in the bacterial genome and their applications

The present invention discloses a strain of bacteria producing DHA and/or EPA, six gene fragments in the bacterial genome, and uses thereof. The strain is Schizoochytrium limacinum HS01, which has the accession number of CGMCC No. 13746 at China General Microbiological Culture Collection Center. The six gene fragments are composed of gene fragment 1 to gene fragment 6, and the nucleotide sequences are sequentially as shown in SEQ ID NO: 3 to SEQ ID NO: 8 in the Sequence Listing. The experiments prove that fermentation broth containing DHA and EPA can be obtained by fermenting Schizoochytrium limacinum HS01; the recombinant strain is obtained by introducing gene fragment 1 to gene fragment 6 into Schizoochytrium limacinum MYA-1381; the ability the recombinant strain for producing DHA and EPA is greatly improved. The bacteria provided by the invention, the six gene fragments, the protein encoded by these six gene fragments, the vector, the cell or the organism containing these six gene fragments all have important application values.

HUMAN AND NON-HUMAN ANIMAL USE OF MICROBIAL ANAPLEROTIC OIL

Disclosed are techniques and systems for producing microbials having anaplerotic oils that are rich in odd-chain fatty acids, and other beneficial components, at higher concentrations than those present in other natural dietary sources of OCFA, at lower cost, and higher production yield. Further, disclosed are examples of incorporation of these higher concentration OCFA products into food for human and non-human animal consumption.

PHOTOBIOREACTORS, GAS CONCENTRATORS, AND PERIODIC SURFACES
20210087506 · 2021-03-25 ·

A system for growing algae includes a photobioreactor comprising a tubular structure having inner and outer surfaces, an annular space defined between the inner and outer surfaces, an inlet to allow an algae slurry to enter the annular space, and a mechanism configured to produce radially-directed contractions and expansions in the tubular structure. At least one of the inner and outer surfaces is transparent to at least some wavelengths of light useful for growing algae within the algae slurry.

Engineered Microorganisms for Producing Substituted Tryptamines

Provided herein are microorganisms for producing substituted tryptamines and cell cultures thereof, the microorganisms comprising at least one exogenous nucleic acid molecule that encodes at least one substituted tryptamine biosynthetic pathway enzyme.

Method of producing biodiesel from microalgae using thermo-responsive switchable solvent

The method for producing biodiesel from microalgae using a thermo-responsive switchable solvent includes mixing a thermo-responsive switchable solvent (TSS) in a hydrophilic state with microalgae at room temperature (25 C.); maintaining the TSS-microalgae mixture in the hydrophilic state for a cell disruption time period; raising the temperature of the TSS-microalgae mixture to switch the TSS solvent to a hydrophobic state; maintaining the TSS solvent in the hydrophobic state in the presence of immobilized lipase catalyst and methanol for an extraction/reaction time period to obtain fatty acid methyl esters (FAMEs) as the oils are extracted; lowering the temperature of the TSS-microalgae mixture to switch the TSS solvent back to the hydrophilic state; and maintaining the TSS solvent in the hydrophilic state for a product separation time period. The method may further include extracting the FAMEs from the TSS-microalgae mixture with a nonpolar organic solvent to obtain the biodiesel product.

USE OF SCHIZOCHYTRIUM LIMACINUM AND ITS PREPARATION IN IMPROVING THE QUALITY AND YIELD OF ANIMAL PRODUCT

The invention discloses the use of the Schizochytrium limacinum and its preparation in improving the quality and yield of animal product. The deposit number of Schizochytrium limacinum in the present invention is CGMCC No. 13746 in the China General Microbiological Culture Collection Center. The Schizochytrium limacinum powder produced by the Schizochytrium limacinum may increase the DHA content in an animal product, reduce the cholesterol content in an animal product, and also improve the egg production performance of poultry. This animal product with high DHA content from natural sources is organic, safe, stable, and easy to be absorbed. It may be used as a safer and effective way for people to ingest natural DHA, and it may also cater to and meet consumer needs. Thus, Schizochytrium limacinum and Schizochytrium limacinum powder of the present application have a wide range of application in the field of general food and livestock breeding.

NOVEL MICROALGAL STRAINS OF THRAUSTOCHYTRIUM GENUS, AND METHOD OF PRODUCING POLYUNSATURATED FATTY ACIDS USING THE SAME

The present disclosure relates to strains of Thraustochyrium genus, including a high content of polyunsaturated fatty acids, and a method of producing a biomass using the same. According to the novel CJM01 microalgae of Thraustochyrium genus of the present disclosure, the content of lipids in the biomass and the content of unsaturated fatty acid such as docosahexaenoic acid in the biomass are high, so that the microalgae itself, a biomass produced by the culturing and fermentation of microalgae, a condensate of the biomass, and a dried product of the biomass are very useful as a feed composition.

Human and non-human animal use of microbial anaplerotic oil

Disclosed are techniques and systems for producing microbials having anaplerotic oils that are rich in odd-chain fatty acids, and other beneficial components, at higher concentrations than those present in other natural dietary sources of OCFA, at lower cost, and higher production yield. Further, disclosed are examples of incorporation of these higher concentration OCFA products into food for human and non-human animal consumption.

Process for preparing an algal powder containing a reduced content of proteins, and bioplastic composition formulated from such a powder
10870733 · 2020-12-22 · ·

A process for preparing an algal powder containing a reduced content of proteins, a bioplastic composition formed from such a powder, a process for manufacturing a plastic product obtained from such an algal powder and also the plastic product obtained in this way. Process for preparing an algal powder, especially intended for the manufacture of a plastic product, including the successive steps of: culturing and/or harvesting an algal biomass; reducing by at least 10% the intrinsic amount of proteins of the algae, by weight relative to the weight of proteins of the harvested biomass; drying; and reducing to give powder or granules.